In vitro and in vivo evaluation of lyophilized bovine bone biocompatibility

Detalhes bibliográficos
Autor(a) principal: Galia, Carlos Roberto
Data de Publicação: 2008
Outros Autores: Macedo, Carlos Alberto, Rosito, Ricardo, Mello, Tielle Muller de, Camargo, Lourdes Maria Araújo Quaresma, Moreira, Luis Fernando
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/17733
Resumo: INTRODUCTION: The use of bone grafts in orthopedic, maxillofacial and dental surgery has been growing. Nevertheless, both fresh autografts and frozen allografts have limitations, and therefore, alternative synthetic or natural biomaterials, such as processed and lyophilized bovine bone graft have been developed. OBJECTIVE: To evaluate in vitro and in vivo biocompatibility of lyophilized bovine bone manufactured in a semi-industrial scale, according to a modifical protocol developed by the authors. METHODS: Samples of bovine cancellous bone were processed according to a protocol developed by Kakiuchi et al., and modified to process samples of bovine cancellous bone. The following trials were performed: in vitro cytotoxicity, in vivo acute systemic toxicity, in vivo oral irritation potential, in vitro pyrogenic reaction, and bioburden. RESULTS: The in vitro evaluation of lyophilized bovine cancellous bone revealed an absence of cytotoxicity in 100% of the samples. Regarding in vivo evaluation of acute systemic toxicity, neither macroscopic abnormalities nor deaths were noted in the animals. Pyrogenicity was not greater than 0.125 UE/ml in any of the samples. The bioburden revealed negative results for microbial growth before sterilization. Regarding the oral irritation potential, in vivo evaluation at 24 and 72 hours showed that the animals had no edema or erythema on the oral mucosa. CONCLUSION: The protocol changes established by the authors to prepare lyophilized bovine cancellous bone at a semi-industrial scale is reproducible and yielded a product with excellent biocompatibility.
id USP-19_c914470e0dae06ef0f69c4b4e0ed5e54
oai_identifier_str oai:revistas.usp.br:article/17733
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling In vitro and in vivo evaluation of lyophilized bovine bone biocompatibility SurgeryMaterials testingToxicity testsFreeze dryingBone transplantation INTRODUCTION: The use of bone grafts in orthopedic, maxillofacial and dental surgery has been growing. Nevertheless, both fresh autografts and frozen allografts have limitations, and therefore, alternative synthetic or natural biomaterials, such as processed and lyophilized bovine bone graft have been developed. OBJECTIVE: To evaluate in vitro and in vivo biocompatibility of lyophilized bovine bone manufactured in a semi-industrial scale, according to a modifical protocol developed by the authors. METHODS: Samples of bovine cancellous bone were processed according to a protocol developed by Kakiuchi et al., and modified to process samples of bovine cancellous bone. The following trials were performed: in vitro cytotoxicity, in vivo acute systemic toxicity, in vivo oral irritation potential, in vitro pyrogenic reaction, and bioburden. RESULTS: The in vitro evaluation of lyophilized bovine cancellous bone revealed an absence of cytotoxicity in 100% of the samples. Regarding in vivo evaluation of acute systemic toxicity, neither macroscopic abnormalities nor deaths were noted in the animals. Pyrogenicity was not greater than 0.125 UE/ml in any of the samples. The bioburden revealed negative results for microbial growth before sterilization. Regarding the oral irritation potential, in vivo evaluation at 24 and 72 hours showed that the animals had no edema or erythema on the oral mucosa. CONCLUSION: The protocol changes established by the authors to prepare lyophilized bovine cancellous bone at a semi-industrial scale is reproducible and yielded a product with excellent biocompatibility. Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2008-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/1773310.1590/S1807-59322008000600016Clinics; Vol. 63 No. 6 (2008); 801-806 Clinics; v. 63 n. 6 (2008); 801-806 Clinics; Vol. 63 Núm. 6 (2008); 801-806 1980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/17733/19798Galia, Carlos RobertoMacedo, Carlos AlbertoRosito, RicardoMello, Tielle Muller deCamargo, Lourdes Maria Araújo QuaresmaMoreira, Luis Fernandoinfo:eu-repo/semantics/openAccess2012-05-22T18:29:21Zoai:revistas.usp.br:article/17733Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2012-05-22T18:29:21Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv In vitro and in vivo evaluation of lyophilized bovine bone biocompatibility
title In vitro and in vivo evaluation of lyophilized bovine bone biocompatibility
spellingShingle In vitro and in vivo evaluation of lyophilized bovine bone biocompatibility
Galia, Carlos Roberto
Surgery
Materials testing
Toxicity tests
Freeze drying
Bone transplantation
title_short In vitro and in vivo evaluation of lyophilized bovine bone biocompatibility
title_full In vitro and in vivo evaluation of lyophilized bovine bone biocompatibility
title_fullStr In vitro and in vivo evaluation of lyophilized bovine bone biocompatibility
title_full_unstemmed In vitro and in vivo evaluation of lyophilized bovine bone biocompatibility
title_sort In vitro and in vivo evaluation of lyophilized bovine bone biocompatibility
author Galia, Carlos Roberto
author_facet Galia, Carlos Roberto
Macedo, Carlos Alberto
Rosito, Ricardo
Mello, Tielle Muller de
Camargo, Lourdes Maria Araújo Quaresma
Moreira, Luis Fernando
author_role author
author2 Macedo, Carlos Alberto
Rosito, Ricardo
Mello, Tielle Muller de
Camargo, Lourdes Maria Araújo Quaresma
Moreira, Luis Fernando
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Galia, Carlos Roberto
Macedo, Carlos Alberto
Rosito, Ricardo
Mello, Tielle Muller de
Camargo, Lourdes Maria Araújo Quaresma
Moreira, Luis Fernando
dc.subject.por.fl_str_mv Surgery
Materials testing
Toxicity tests
Freeze drying
Bone transplantation
topic Surgery
Materials testing
Toxicity tests
Freeze drying
Bone transplantation
description INTRODUCTION: The use of bone grafts in orthopedic, maxillofacial and dental surgery has been growing. Nevertheless, both fresh autografts and frozen allografts have limitations, and therefore, alternative synthetic or natural biomaterials, such as processed and lyophilized bovine bone graft have been developed. OBJECTIVE: To evaluate in vitro and in vivo biocompatibility of lyophilized bovine bone manufactured in a semi-industrial scale, according to a modifical protocol developed by the authors. METHODS: Samples of bovine cancellous bone were processed according to a protocol developed by Kakiuchi et al., and modified to process samples of bovine cancellous bone. The following trials were performed: in vitro cytotoxicity, in vivo acute systemic toxicity, in vivo oral irritation potential, in vitro pyrogenic reaction, and bioburden. RESULTS: The in vitro evaluation of lyophilized bovine cancellous bone revealed an absence of cytotoxicity in 100% of the samples. Regarding in vivo evaluation of acute systemic toxicity, neither macroscopic abnormalities nor deaths were noted in the animals. Pyrogenicity was not greater than 0.125 UE/ml in any of the samples. The bioburden revealed negative results for microbial growth before sterilization. Regarding the oral irritation potential, in vivo evaluation at 24 and 72 hours showed that the animals had no edema or erythema on the oral mucosa. CONCLUSION: The protocol changes established by the authors to prepare lyophilized bovine cancellous bone at a semi-industrial scale is reproducible and yielded a product with excellent biocompatibility.
publishDate 2008
dc.date.none.fl_str_mv 2008-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/17733
10.1590/S1807-59322008000600016
url https://www.revistas.usp.br/clinics/article/view/17733
identifier_str_mv 10.1590/S1807-59322008000600016
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/17733/19798
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 63 No. 6 (2008); 801-806
Clinics; v. 63 n. 6 (2008); 801-806
Clinics; Vol. 63 Núm. 6 (2008); 801-806
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222753450622976